Plasma from vaccinated and COVID-19 convalescent subjects as passive immunotherapy against the new Omicron BQ.1.1, XBB, and BF.7 variants

In a recent study posted to bioRxiv*, researchers systematically reviewed severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Omicron BQ.1.1 neutralization data from individual patient samples. Study: Plasma after both SARS-CoV-2 …

Plasma from vaccinated and COVID-19 convalescent subjects as passive immunotherapy against the new Omicron BQ.1.1, XBB, and BF.7 variants Read More

Broadly cross-reactive antibodies that protect from SARS-CoV-2 variants are revealed by virus coldspot-driven discovery

A recent study posted to bioRxiv* identified neutralizing antibodies (nAbs) against conserved severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) epitopes. Study: Human neutralizing antibodies to cold linear epitopes and to …

Broadly cross-reactive antibodies that protect from SARS-CoV-2 variants are revealed by virus coldspot-driven discovery Read More

The evolutionary trajectories and mechanisms driving the emergence of post-Omicron SARS-CoV-2 lineages

In a recent report posted on Virological*, a discussion forum for analysis of virus genomes, researchers summarized the mechanisms through which the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) new Omicron sublineages …

The evolutionary trajectories and mechanisms driving the emergence of post-Omicron SARS-CoV-2 lineages Read More